News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Fabrinet reported blowout revenue as AI optics demand surged, prompting mid‑term valuation catch‑up long ideas.
  • Accenture is positioned to monetize generative AI (Anthropic) rollouts, fueling mid‑term services re‑rating trade plans.
  • Nano Labs attracts both deep‑value long and high‑risk short calls after pivoting toward AI while facing crypto losses and a large write‑down.
  • McDonald's pullback near its 52‑week low is pitched as a long based on strong free cash flow and a steady dividend.
  • Amerigo Resources has shed its deep‑value label but still offers yield and copper upside as a position for income and cash flow optionality.
  • BlackBerry upgraded to a tactical buy ahead of Q2, with QNX momentum and improving cash flow seen as potential catalysts for a rebound.
  • Journey Medical’s Emrosi approval positions the stock for re‑rating, contingent on reimbursement execution and ongoing legal and short‑interest risks.

Latest Articles

Itron Announces Second Quarter 2026 Financial Results

Itron Announces Second Quarter 2026 Financial Results

Itron, Inc. announced its second quarter 2026 financial results showing a 7% revenue decline to $563 million but achieved record gross margins and an 8% increase in adjusted EBITDA. Despite decreases in GAAP net income and diluted EPS, the company raised its full-year earnings outlook based on a stronger operating model and constructive demand driv…

Bicara Therapeutics Announces Appointments of Jeremy Bender and Christy Oliger to Board of Directors

Bicara Therapeutics Announces Appointments of Jeremy Bender and Christy Oliger to Board of Directors

Bicara Therapeutics, a Nasdaq-listed clinical-stage biopharmaceutical company, announced the appointment of Jeremy Bender and Christy Oliger to its Board of Directors. These additions bring extensive experience in biotechnology strategy, commercialization, and oncology, supporting Bicara's transition towards delivering its lead therapeutic candidat…

OneMedNet Secures $11.5+ Million Agreement to Supply Regulatory-Grade Real-World Data for Foundational AI Model Development

OneMedNet Secures $11.5+ Million Agreement to Supply Regulatory-Grade Real-World Data for Foundational AI Model Development

OneMedNet Corporation has secured an agreement exceeding $11.5 million to provide its regulatory decision-grade, de-identified real-world healthcare data via its iRWD™ platform for use in developing foundational AI models. The deal highlights OneMedNet's ability to supply large-scale, secure, and privacy-compliant multi-modal healthcare datasets es…

Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship

Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship

Dentsply Sirona announced an expansion of its relationship with Medline Sinclair in Canada, extending beyond consumables to include the full technology portfolio. Effective September 1, 2026, this partnership will enhance access to digital dentistry solutions through Medline Sinclair's extensive national sales, service, and technical network. This …

Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call

Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call

Neuronetics, Inc., a leader in interventional mental health and provider of NeuroStar TMS technology and SPRAVATO therapies through its Greenbrook clinics, announced its plan to release second quarter 2026 financial and operating results on August 11, 2026, followed by a conference call. The company highlights its FDA-cleared NeuroStar Advanced The…

Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days

Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days

Dyadic International announced the rapid development and initial purification of two Scripps-designed Bundibugyo ebolavirus recombinant protein antigens using its proprietary C1 fungal protein production platform within about 15 days. These antigens have been delivered for preclinical evaluation to support potential non-mRNA vaccine candidates targ…

MindWave Innovations Inc., a Wholly Owned Subsidiary of Apimeds Pharmaceuticals US, Inc., Announces MindChain: World's First Fully Insured Blockchain, Launching in October

MindWave Innovations Inc., a Wholly Owned Subsidiary of Apimeds Pharmaceuticals US, Inc., Announces MindChain: World's First Fully Insured Blockchain, Launching in October

MindWave Innovations Inc., a subsidiary of Apimeds Pharmaceuticals (NYSE American: APUS), announced MindChain, the first fully insured, production-grade Ethereum-compatible Layer 2 blockchain, launching in October 2026. The NILA token will become the native asset of this blockchain and will be available for U.S. trading on the licensed Webot exchan…

SEGG Media Amends Lawsuit Against White Diamond Research and Increases Damages Sought to $35 Million

SEGG Media Amends Lawsuit Against White Diamond Research and Increases Damages Sought to $35 Million

Sports Entertainment Gaming Global Corporation (SEGG Media) has amended its lawsuit against White Diamond Research LLC and Adam Gefvert, increasing the damages sought from $20 million to $35 million. The company alleges that false and disparaging statements by the defendants triggered a continued decline in SEGG's stock price, harming shareholder v…

BofA Says a July Fed Rate Hike Would Break with Decades of Practice

BofA Says a July Fed Rate Hike Would Break with Decades of Practice

Bank of America expects the Federal Reserve to keep policy rates unchanged at its July meeting, warning that a surprise uptick would violate long-standing market norms. Analyst Mark Cabana identified a hold as the base case with two dissents, and the bank points to futures pricing, oil-driven inflation risk, and the statistical record since 1994 to…

Gaxos Sharpens Focus to Accelerate Growth Across Revenue-Generating AI and Health and Wellness Platforms

Gaxos Sharpens Focus to Accelerate Growth Across Revenue-Generating AI and Health and Wellness Platforms

Gaxos.ai Inc. announced the sale of its gaming assets to concentrate on its revenue-generating AI applications and personalized health and wellness products. The company reported a significant increase in Q1 2026 revenue to $1.81 million, driven largely by RNK Health and Gaxos Labs subscriptions. The strategic realignment aims to enhance customer a…

Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery Campaign

Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery Campaign

Nexentis Technologies' wholly owned subsidiary, MitoCareX Bio Ltd., has completed its internal prioritization process and selected a candidate SLC transport protein for an upcoming drug discovery campaign. This decision follows broad structural analysis enabled by the proprietary MITOLINE® algorithm, reflecting tangible progress in Nexentis' drug d…

Noble Shares Drop After Q2 Miss, Guidance Cut and Rig Suspensions

Noble Shares Drop After Q2 Miss, Guidance Cut and Rig Suspensions

Noble Corp reported a weak second quarter with an adjusted EPS of $0.01 versus the $0.19 analyst consensus, a $37 million net loss, and a downward revision to full-year revenue guidance. Operational suspensions of two Brazil rigs and the end of a Black Sea contract were cited as key drivers of the revenue decline and negative free cash flow, prompt…

FactSet expands partnership with RepRisk to strengthen sustainable investing solutions suite for clients

FactSet expands partnership with RepRisk to strengthen sustainable investing solutions suite for clients

FactSet has expanded its partnership with RepRisk to integrate RepRisk's business conduct risk intelligence solutions into its sustainable investing suite. This collaboration provides FactSet clients with enhanced risk data and analytics across investment workflows to better identify, monitor, and manage business conduct risks and support more info…

Safe Pro Group to Host SPAI Innovation Day Featuring Live AI Powered Drone Field Operations on August 25, 2026

Safe Pro Group to Host SPAI Innovation Day Featuring Live AI Powered Drone Field Operations on August 25, 2026

Safe Pro Group Inc., a Nasdaq-listed AI-enabled security and defense technology company, announced it will hold an Innovation Day on August 25, 2026, in Aventura, Florida. The event will demonstrate live drone operations using their AI-powered threat detection technology, including the patented SPOTD system and NODE edge compute solution. The compa…

VeriSign Upgrade: Buy the Dip Into Durable DNS Cash Flow

VeriSign Upgrade: Buy the Dip Into Durable DNS Cash Flow

VeriSign's domain-registry monopoly and heavy free cash flow profile justify a renewed buy thesis after recent weakness. The stock has pulled back into technical support while fundamentals - $1.07B in FCF, near-$25B market cap, and expanding buyback activity - underwrite upside. We lay out an entry at $274.81, a $252 stop and a $310 target over a 4…

Pluri Advances Commercial Expansion Through Its Subsidiary Cellav, Completing Regulatory Registration in the UK

Pluri Advances Commercial Expansion Through Its Subsidiary Cellav, Completing Regulatory Registration in the UK

Pluri Inc., through its subsidiary Cellav Health and Aesthetics Ltd., has completed cosmetic regulatory registration for its regenerative aesthetics product, Regenativo+, in the UK. This milestone allows commercial launch in the UK market, estimated at $900 million annually, and supports the company's broader strategy to expand globally in regenera…